Physician
Darsalud Community Center INC
Darsalud Community Center INC was paid $12.38M by Medicaid between Jan 2021 and Dec 2024, across 166 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoDARSALUD COMMUNITY CENTER INC
MEMPHIS, TN 38115
MEMPHIS, TN 38115
33aNPI1174184709assigned 06/25/2019
33bProvider typeGeneral Practice Physician
28Total paid$12.38M
24GClaims532,821
24DCodes billed166
24AFirst – last monthJan 2021 – Dec 2024
Compared with peers
Next to other General Practice Physician providers in Tennessee
Rank by total paid#2 of 47
Median peer was paid$64K
This provider vs. median194×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 109,712 | $2.64M | |
| 2022 | 131,109 | $3.06M | |
| 2023 | 149,461 | $3.48M | |
| 2024incomplete | 142,539 | $3.20M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 70,163 | 52,108 | $4.04M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.4% | 25,603 | 20,472 | $1.04M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.7% | 15,592 | 11,472 | $579K |
| 98966 | 4.6% | 10,773 | 9,132 | $573K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 4.1% | 27,255 | 21,009 | $511K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.1% | 6,379 | 5,202 | $506K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 3.1% | 5,457 | 4,624 | $383K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.0% | 5,213 | 4,330 | $375K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.9% | 5,078 | 3,900 | $358K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 2.6% | 4,038 | 3,160 | $328K |
| 92015 | Determination of refractive state | 2.4% | 11,839 | 8,592 | $298K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.7% | 1,778 | 1,467 | $216K |
154 more codes
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1.5% | 3,856 | $190K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.5% | 5,374 | $182K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.4% | 2,737 | $175K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 1.4% | 8,623 | $170K |
| 99384 | 1.2% | 1,708 | $148K | |
| 99204 | Doctor's office visit, new patient (more involved) | 1.1% | 1,900 | $140K |
| 92551 | 1.0% | 17,027 | $124K | |
| 99401 | <1% | 4,368 | $113K | |
| 93015 | <1% | 1,956 | $111K | |
| 99605 | <1% | 2,166 | $110K | |
| 96160 | <1% | 6,416 | $101K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 4,848 | $90K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 9,019 | $89K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,314 | $88K |
| 93000 | <1% | 6,431 | $78K | |
| 99173 | <1% | 17,016 | $75K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 1,475 | $74K |
| 92250 | <1% | 3,086 | $73K | |
| 82962 | <1% | 35,686 | $71K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,317 | $66K |
| V2020 | Frames, purchases | <1% | 3,970 | $59K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,852 | $54K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,418 | $51K |
| 97750 | <1% | 3,787 | $47K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 2,245 | $39K |
| 99606 | <1% | 1,177 | $38K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 5,816 | $38K |
| 96127 | <1% | 9,452 | $36K | |
| 83037 | <1% | 6,551 | $32K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,216 | $32K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 503 | $32K |
| 36416 | <1% | 24,529 | $28K | |
| 99402 | <1% | 898 | $25K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,498 | $25K |
| 93922 | <1% | 1,073 | $24K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 309 | $22K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 1,001 | $21K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 283 | $19K |
| 99383 | <1% | 234 | $17K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 2,367 | $16K |
| V2104 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | <1% | 914 | $14K |
| 81025 | <1% | 3,784 | $14K | |
| 99385 | <1% | 215 | $14K | |
| 90686 | <1% | 2,868 | $12K | |
| 90651 | <1% | 1,603 | $11K | |
| 81003 | <1% | 8,678 | $10K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 501 | $10K |
| 99381 | <1% | 157 | $9K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 168 | $8K |
| 0012A | <1% | 241 | $8K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 505 | $8K |
| 0011A | <1% | 316 | $7K | |
| 76770 | <1% | 162 | $7K | |
| 90697 | <1% | 616 | $7K | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 339 | $6K |
| 90734 | <1% | 1,926 | $5K | |
| 83655 | <1% | 479 | $5K | |
| 0071A | <1% | 122 | $5K | |
| 92002 | <1% | 167 | $5K | |
| 3079F | <1% | 3,470 | $4K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 267 | $4K |
| 85013 | <1% | 868 | $4K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 61 | $4K |
| 3074F | <1% | 4,949 | $4K | |
| 3078F | <1% | 3,526 | $3K | |
| 0358T | <1% | 3,900 | $3K | |
| 90674 | <1% | 387 | $3K | |
| 99177 | <1% | 6,052 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,918 | $3K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 58 | $3K |
| 76536 | <1% | 58 | $3K | |
| 99382 | <1% | 47 | $3K | |
| 3077F | <1% | 1,629 | $2K | |
| G0473 | Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes | <1% | 254 | $2K |
| 87807 | <1% | 246 | $2K | |
| 85018 | <1% | 876 | $2K | |
| 82951 | <1% | 1,811 | $2K | |
| 90461 | <1% | 2,903 | $2K | |
| 3008F | <1% | 30,766 | $2K | |
| 3080F | <1% | 884 | $2K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 27 | $2K |
| 90656 | <1% | 443 | $1K | |
| 99441 | <1% | 71 | $1K | |
| 90688 | <1% | 403 | $1K | |
| 90620 | <1% | 1,119 | $1K | |
| 3075F | <1% | 1,164 | $1K | |
| 82952 | <1% | 1,819 | $1K | |
| 92552 | <1% | 54 | $1K | |
| 0064A | <1% | 39 | $981.86 | |
| 99490 | Ccm add 20min | <1% | 49 | $820.41 |
| 90672 | <1% | 68 | $782.10 | |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 36 | $742.39 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 24 | $741.71 |
| 92310 | <1% | 13 | $605.79 | |
| 92134 | <1% | 41 | $592.95 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 15 | $512.92 |
| 99442 | <1% | 15 | $476.55 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 1,518 | $439.05 |
| 90715 | <1% | 459 | $349.90 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 42 | $317.38 |
| 80061 | Lipid panel | <1% | 188 | $290.10 |
| 90716 | <1% | 339 | $142.48 | |
| 90661 | <1% | 524 | $140.43 | |
| 90681 | <1% | 63 | $125.29 | |
| 3072F | <1% | 29 | $120.00 | |
| 2022F | <1% | 728 | $120.00 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 43 | $108.23 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 18 | $91.27 |
| 36000 | <1% | 1,848 | $85.44 | |
| 90655 | <1% | 830 | $82.76 | |
| 90707 | <1% | 339 | $82.51 | |
| 90650 | <1% | 182 | $75.00 | |
| 90633 | <1% | 1,171 | $62.86 | |
| 83704 | <1% | 204 | $46.90 | |
| 90658 | <1% | 445 | $43.16 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 38 | $34.24 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 92 | $26.32 |
| 90677 | <1% | 841 | $2.41 | |
| 91301 | <1% | 565 | $0.93 | |
| 90670 | <1% | 2,019 | $0.21 | |
| 91307 | <1% | 122 | $0.10 | |
| 90680 | <1% | 377 | $0.09 | |
| 91306 | <1% | 39 | $0.06 | |
| 90723 | <1% | 330 | $0.05 | |
| 2028F | <1% | 4,204 | $0.05 | |
| 90648 | <1% | 751 | $0.05 | |
| 3044F | <1% | 1,407 | $0.02 | |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | <1% | 560 | $0.02 |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | <1% | 131 | $0.01 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 622 | $0.01 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | <1% | 115 | $0.01 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 2,809 | $0.01 |
| 99000 | 0% | 2,741 | $0.00 | |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | 0% | 110 | $0.00 |
| 2023F | 0% | 258 | $0.00 | |
| 90696 | 0% | 127 | $0.00 | |
| 90698 | 0% | 66 | $0.00 | |
| 36591 | 0% | 36 | $0.00 | |
| 90657 | 0% | 252 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 20 | $0.00 |
| G8430 | Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an acute health crisis where time is of the essence and delay of treatment would jeopardize the patient's health status) | 0% | 32 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 21 | $0.00 |
| 99072 | 0% | 7,404 | $0.00 | |
| 3051F | 0% | 78 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 1,521 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 767 | $0.00 |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 25 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 330 | $0.00 |
| 3046F | 0% | 310 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 251 | $0.00 |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 577 | $0.00 |
| 82947 | 0% | 16 | $0.00 | |
| 90700 | 0% | 41 | $0.00 | |
| 90710 | 0% | 85 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialIVORY FULLER, ANDREA (BILLING AND CREDENTIALING MANAGER)